Unique ID issued by UMIN | UMIN000053075 |
---|---|
Receipt number | R000060563 |
Scientific Title | Analysis of the Effect of Preconception Care on Male Fertility |
Date of disclosure of the study information | 2023/12/12 |
Last modified on | 2024/06/12 15:40:03 |
Analysis of the Effect of Preconception Care on Male Fertility
Analysis of the Effect of Preconception Care on Male Fertility
Analysis of the Effect of Preconception Care on Male Fertility
Male preconception care
Japan |
male infertility
Urology |
Others
YES
As preconception care for men, lifestyle modification and nutritional dietary guidance that may affect male fertility will be provided. As a result, we will verify whether semen findings, oxidative stress in semen, sperm DNA fragmentation, or changes in the sperm epigenome are improved as male fertility, and clarify the significance of this care.
Efficacy
Exploratory
Phase I
Changes in semen findings, sORP, DFI, microRNA expression, and diet before and after lifestyle diet modification guidance and urologic intervention
1) Association of lifestyle and diet with primary endpoints; 2) Association of male factors with primary endpoints; 3) Correlation of primary endpoints with pregnancy rate, time to pregnancy, miscarriage rate, and live birth rate
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
NO
NO
Institution is not considered as adjustment factor.
1
Treatment
Food | Behavior,custom |
Lifestyle guidance and nutritional dietary guidance will be provided once at the time of registration.
18 | years-old | <= |
Not applicable |
Male
1) Male patients who are 18 years of age or older at the time of consent
2) Patients who have visited Chiba University Hospital or Kameda IVF Clinic Makuhari with the intention of conception.
3) Patients who have received a thorough explanation of their participation in this study, and who have given written consent of their own free will based on a thorough understanding of the study.
1) Patients undergoing treatment for any of the following diseases that may affect the results of the study; malignant tumors (including pre-existing), uncontrolled allergic diseases
2) Taking any of the following medications that may affect the study results; Salazopyrine, finasteride, dutasteride, other hormonal drugs, psychotropic drugs, SSRIs, SNRIs, methotrexate
3) Patients with azoospermia
4) Those who have undergone infertility treatment in the past
5) Those who have participated in other clinical trials within one month prior to obtaining consent
6) Other subjects who are deemed by the investigator to be inappropriate for the study (i.e., study implementation may increase the risk to study subjects or may not provide sufficient data)
100
1st name | Akira |
Middle name | |
Last name | Komiya |
Chiba University Graduate School of Medicine
Department of Urology
260-8670
1-8-1 Inohana Chuo-ku, Chiba-shi, Chiba, Japan
043-226-2134
komiya@chiba-u.jp
1st name | Akira |
Middle name | |
Last name | Komiya |
Chiba University Hospital
Department of Urology
260-8677
1-8-1 Inohanam Chuo-ku, Chiba-shi, Chiba, Japan
043-226-2134
komiya@chiba-u.jp
Chiba University Hospital
Ministry of Education, Culture, Sports, Science and Technology
Japanese Governmental office
Kameda IVF Clinic Makuhari
Research Bioethics Committee of Chiba University Hospital
1-8-1 Inohana, Chuo-ku, Chiba-shi, Chiba, Japan
043-222-7171
hsp-seimei@chiba-u.jp
NO
2023 | Year | 12 | Month | 12 | Day |
Unpublished
Open public recruiting
2023 | Year | 07 | Month | 12 | Day |
2023 | Year | 07 | Month | 12 | Day |
2023 | Year | 12 | Month | 16 | Day |
2026 | Year | 03 | Month | 31 | Day |
2026 | Year | 03 | Month | 31 | Day |
2023 | Year | 12 | Month | 12 | Day |
2024 | Year | 06 | Month | 12 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000060563